Back to Journals » Cancer Management and Research » Volume 12
Original Research
Efficacy and Safety of Anlotinib for Patients with Advanced NSCLC Who Progressed After Standard Regimens and the Preliminary Analysis of an Efficacy Predictor
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
4,775 | Dovepress* | 4,270+ | 788 | 5,058 | |
PubMed Central* | 505 | 178 | 683 | ||
Totals | 4,775 | 966 | 5,741 | ||
*Since 12 July 2020 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
14 | 0 | 0 | 0 | 3 | 11 |
View citations on PubMed Central and Google Scholar